In conclusion, this study demonstrated that CZYH attenuates cognitive impairments and neuron loss induced by Aβ25-35, owing to its anti-inflammatory effects via the suppression of JNK phosphorylation and the blockade of the NF-κB/IκB-α pathway. Here, NFKB1 is linked to Cognitive impairment.